Founders Financial Securities LLC purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,382 shares of the financial services provider’s stock, valued at approximately $2,483,000.
Several other institutional investors have also added to or reduced their stakes in MRSH. Norges Bank purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at approximately $1,555,869,000. Ninety One UK Ltd grew its holdings in Marsh & McLennan Companies by 163.0% during the 4th quarter. Ninety One UK Ltd now owns 3,542,004 shares of the financial services provider’s stock valued at $657,113,000 after buying an additional 2,195,201 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in Marsh & McLennan Companies by 9,455.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,520,164 shares of the financial services provider’s stock valued at $282,021,000 after buying an additional 1,504,255 shares in the last quarter. BNP Paribas Financial Markets purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at approximately $267,251,000. Finally, Wellington Management Group LLP grew its holdings in Marsh & McLennan Companies by 9.1% during the 3rd quarter. Wellington Management Group LLP now owns 15,091,478 shares of the financial services provider’s stock valued at $3,041,386,000 after buying an additional 1,260,434 shares in the last quarter. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Performance
Shares of MRSH stock opened at $159.73 on Monday. Marsh & McLennan Companies, Inc. has a 52-week low of $157.74 and a 52-week high of $235.78. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The company has a market cap of $77.17 billion, a price-to-earnings ratio of 19.97, a P/E/G ratio of 2.33 and a beta of 0.62. The business’s 50 day simple moving average is $164.87.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on MRSH. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, May 6th. Cantor Fitzgerald lifted their target price on Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an “overweight” rating in a report on Monday, February 2nd. Mizuho dropped their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a report on Monday, April 13th. Weiss Ratings cut Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 target price for the company in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $203.56.
View Our Latest Report on MRSH
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $21,411,456.30. The trade was a 12.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.38% of the stock is currently owned by company insiders.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
